This Biotech Stock Has 47% Upside, According to 1 Wall Street Analyst
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
With shares of Iovance Biotherapeutics (NASDAQ: IOVA) soaring by 175% in the last three months, Wells Fargo analyst Yanan Zhu thinks they could still go as much as 47% higher. In fact, on Feb. 20, the analyst raised his price target for the stock from $17 to $22. Yanan wasn’t alo
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2159746556-2e3b77ab7fc54f1b97c114d57974e4f1.jpg "What Happens to Your Money When Your Fintech Company Goes Bust?")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-119717054-dc96ff6f97be43ca89b9d19f53318a70-a8d2635c71d54da794bbfdc95d522e44.jpg "<div>Yes, You Can Retire on a Cruise Ship. Here's What It Costs</div>")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-469310035-6b91d5b65b7449c5882b4144acd14206.jpg "Correlation Coefficients: Positive, Negative, and Zero")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-497277330-0ce0bc2661664a18ac4476b5be0eaa8d.jpg "On Which Financial Statements Do Companies Report Long-Term Debt?")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1055247044-c1c66750541b4532813e54d8bc5a1854.jpg "<div>Credit Rating vs. Equity Research: What's the Difference?</div>")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-518595670-91421a5730064d22b00fb052e694fdc8.jpg "<div>A Beginners' Guide to Managing Your Money</div>")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2150743060-75c2828f7a4a4e13bf6af0d58576e290.jpg "How Starbucks Makes Money")